Clinical trial
Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
NCT00406094 · Bernstein, Jonathan A., M.D., Other · Unknown status
Key facts
| NCT number | NCT00406094 |
|---|---|
| Title | Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) |
| Official title | The Evaluation of Singulair for the Treatment of Non-Allergic Rhinitis Eosinophil Syndrome (NARES) |
| Lead sponsor | Bernstein, Jonathan A., M.D., Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhinitis |
| Intervention type | Drug |
| Interventions | montelukast, placebo |
| Enrollment | 6 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Jan 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: